NO933837L - 4-aryl-3-(heteroarylureido)kinolin-derivater - Google Patents

4-aryl-3-(heteroarylureido)kinolin-derivater

Info

Publication number
NO933837L
NO933837L NO933837A NO933837A NO933837L NO 933837 L NO933837 L NO 933837L NO 933837 A NO933837 A NO 933837A NO 933837 A NO933837 A NO 933837A NO 933837 L NO933837 L NO 933837L
Authority
NO
Norway
Prior art keywords
heteroarylureido
aryl
quinoline derivatives
compounds
formula
Prior art date
Application number
NO933837A
Other languages
English (en)
Norwegian (no)
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO933837L publication Critical patent/NO933837L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO933837A 1991-04-26 1993-10-25 4-aryl-3-(heteroarylureido)kinolin-derivater NO933837L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (1)

Publication Number Publication Date
NO933837L true NO933837L (no) 1993-10-25

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933837A NO933837L (no) 1991-04-26 1993-10-25 4-aryl-3-(heteroarylureido)kinolin-derivater

Country Status (20)

Country Link
EP (1) EP0590094A1 (xx)
JP (1) JPH0776215B2 (xx)
CN (1) CN1066068A (xx)
AU (1) AU1879792A (xx)
BR (1) BR9205939A (xx)
CA (1) CA2108014A1 (xx)
CZ (1) CZ395592A3 (xx)
DE (1) DE9290049U1 (xx)
FI (1) FI934710A0 (xx)
HU (1) HUT65748A (xx)
IE (1) IE921330A1 (xx)
IL (1) IL101627A0 (xx)
MX (1) MX9201916A (xx)
NO (1) NO933837L (xx)
NZ (1) NZ242493A (xx)
PT (1) PT100426A (xx)
TW (1) TW197436B (xx)
WO (1) WO1992019614A1 (xx)
YU (1) YU44592A (xx)
ZA (1) ZA922976B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125325T3 (es) * 1992-01-23 1999-03-01 Pfizer Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives
NZ335766A (en) * 1996-11-26 2000-11-24 Sumitomo Pharma Naphthyridine derivatives and use as acyl-CoA cholesterol acyl transferase(ACAT) inhibitor as treatment of hyperlipidemia
AU2547399A (en) 1998-02-25 1999-09-15 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for producing the same
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
BRPI0417543A (pt) * 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
TW205037B (xx) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
HUT65748A (en) 1994-07-28
TW197436B (xx) 1993-01-01
CA2108014A1 (en) 1992-10-27
HU9303025D0 (en) 1994-01-28
FI934710A (fi) 1993-10-25
JPH0776215B2 (ja) 1995-08-16
PT100426A (pt) 1993-08-31
AU1879792A (en) 1992-12-21
BR9205939A (pt) 1994-09-27
NZ242493A (en) 1994-08-26
IL101627A0 (en) 1992-12-30
ZA922976B (en) 1993-10-25
CN1066068A (zh) 1992-11-11
FI934710A0 (fi) 1993-10-25
YU44592A (sh) 1994-12-28
MX9201916A (es) 1992-11-01
WO1992019614A1 (en) 1992-11-12
IE921330A1 (en) 1992-11-04
EP0590094A1 (en) 1994-04-06
JPH06501025A (ja) 1994-01-27
DE9290049U1 (de) 1994-01-05
CZ395592A3 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
DK0609960T3 (da) Nye N-heteroarylamidderivater som inhibitorer af acylcoenzym-A: cholesterolacyltransferase
FI96947C (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
CY2488B1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for trea.
NO307047B1 (no) Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav
NO981485D0 (no) Nye heterocykliske derivater og farmasöytisk anvendelse av disse
AU679021B2 (en) N-heteroaryl-N'-phenylurea derivatives, their production and use
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
FI962418A (fi) Syklisiä amidijohdannaisia neurokiniini A antagonisteina
EP0632031A4 (xx)
NO304833B1 (no) Nye pyrrolokarbazoler
NO933837L (no) 4-aryl-3-(heteroarylureido)kinolin-derivater
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
DK0595557T3 (da) Nye substituerede azetidoner som antiinflammatoriske og antidegenerative midler
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
EP0760362A4 (en) NEW DIAMINOMETHYLIDES DERIVATIVES
DK0664799T3 (da) Amidderivater
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
NO20002575L (no) Substituerte oksimer som neurokininantagonister
FI953994A0 (fi) Menetelmä (-)-N-metyyli-N-(4-(4-fenyyli-4-asetyyliaminopiperidiini-1-yl)-2-(3,4-diklorofenyyli)butyyli)bentsamidi ja sen farmaseuttisesti hyväksyttäviä suoloja